Atossa Therapeutics, Inc. announced that Tessa Cigler, M.D., M.P.H. was appointed to Atossa?s board of directors, effective immediately. Dr. Cigler is a medical oncologist and clinical investigator at the Weill Cornell Breast Center in New York City. Dr. Cigler received her undergraduate degree from Harvard College, and her M.D. from Duke University School of Medicine.

She also holds a Master?s in Public Health from the Harvard School of Public Health. She completed her residency in Internal Medicine at the New York Presbyterian Hospital Weill Cornell Medical Center, followed by a fellowship in Medical Oncology and Hematology at the Dana-Farber Harvard Cancer Center. Dr. Cigler joined the Cornell faculty in August 2007 as a medical oncologist and clinical investigator at the Weill Cornell Breast Center.

At Weill Cornell, she heads several clinical trials designed to provide patients with access to new and promising options for therapy and supportive care.